Impact of dopamine agonists on compulsive behaviors: A case series of pramipexole-induced pathological gambling

Psychosomatics

Volumn 51, Issue 3, 2010, Pages 271-273

  Kolla, Bhanu Prakash ^a   Mansukhani, Meghna Prabhdas ^a   Barraza, Román ^a   Bostwick, John Michael ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRAMIPEXOLE; ROPINIROLE; BENZOTHIAZOLE DERIVATIVE; DOPAMINE RECEPTOR STIMULATING AGENT; INDOLE DERIVATIVE;

ADULT; AGED; ARTICLE; CASE REPORT; COMPULSION; DEPRESSION; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HUMAN; MALE; PATHOLOGICAL GAMBLING; RESTLESS LEGS SYNDROME; SPIRITUAL CARE; SUICIDE ATTEMPT; SUPPORT GROUP; CHEMICALLY INDUCED; COMPULSIVE BEHAVIOR; DEPRESSIVE DISORDER; DISRUPTIVE, IMPULSE CONTROL, AND CONDUCT DISORDERS; GAMBLING; MIDDLE AGED; PSYCHOLOGY;

AGED; BENZOTHIAZOLES; COMPULSIVE BEHAVIOR; DEPRESSIVE DISORDER; DISRUPTIVE, IMPULSE CONTROL, AND CONDUCT DISORDERS; DOPAMINE AGONISTS; GAMBLING; HUMANS; INDOLES; MALE; MIDDLE AGED; RESTLESS LEGS SYNDROME; SUICIDE, ATTEMPTED;

EID: 77953075821     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.psy.51.3.271     Document Type: Article

References (9)

1. Bostwick JM, Hecksel KA, Stevens SR, et al: Frequency of new-onset pathological gambling or hypersexuality after drug treatment of idiopathic Parkinson's disease. Mayo Clinic Proceedings 2009; 84:310-316
2. Driver-Dunckley E, Samanta J, Stacy M: Pathological gambling associated with dopamine agonist therapy in Parkinson's disease. Neurology 2003; 61:422-423 (Pubitemid 36975988)
3. Tippmann-Peikert MM, Park JG, Boeve BF, et al: Pathologic gambling in patients with restless legs syndrome treated with dopaminergic agonists. Neurology 2007; 68:301-303 (Pubitemid 46148346)
4. Quickfall J, Suchowersky O: Pathological gambling associated with dopamine agonist use in restless legs syndrome. Parkinsonism Relat Disord 2007; 13:535-536 (Pubitemid 350110554)
5. 3 dopamine receptor mRNA is widely expressed in the human brain. Brain Research 1998; 779(1-2):58-74
6. Riba J, Krämer UM, Heldmann M, et al: Dopamine agonist increases risk-taking but blunts reward-related brain activity. PLoS ONE 2008; 3:e2479
7. Aiken CB: Pramipexole in psychiatry: a systematic review of the literature. J Clin Psychiatry 2007; 68:1230-2126
8. Klos KJ, Bower JH, Josephs KA, et al: Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy. Parkinsonism Relat Disord 2005; 11:381-386
9. Melissa J, Nirenberg CW: Compulsive eating and weight gain related to dopamine agonist use. Mov Disord 2006; 21:524-529